Heme oxygenase-1 protects against apoptosis induced by tumor necrosis factor-α and cycloheximide in papillary thyroid carcinoma cells

Journal of Cellular Biochemistry

Volumn 92, Issue 6, 2004, Pages 1246-1256

  Chen, George G ^a   Liu, Z M ^a   Vlantis, A C ^a   Tse, G M K ^a   Leung, B C H ^a   Van Hasselt, C A ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Heme oxygenase 1; p21; Thyroid cancer

Indexed keywords

CADMIUM; CYCLOHEXIMIDE; HEME OXYGENASE 1; HEMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P21; TUMOR NECROSIS FACTOR ALPHA; HEME OXYGENASE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THYROID CARCINOMA; CELL CYCLE; CELL SEPARATION; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; PAPILLARY CARCINOMA; PATHOLOGY; PHYSIOLOGY; THYROID TUMOR; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; CADMIUM; CARCINOMA, PAPILLARY; CELL CYCLE; CELL LINE, TUMOR; CELL SEPARATION; CYCLOHEXIMIDE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEME OXYGENASE (DECYCLIZING); HUMANS; NF-KAPPA B; THYROID NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 16644385572     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20157     Document Type: Article

References (32)

1. Arscott PL, Stokes T, Myc A, Giordano NW, Thompson NW, Baker JR, Jr. 1999. Fas (CD95) expression is upregulated on papillary thyroid carcinoma. J Clin Endocrinol Metab 84:4246-4252.
2. Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W, Moncayo R. 1997. Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 7:733-741.
3. Boltze C, Brabant G, Dralle H, Gerlach R, Roessner A, Hoang-Vu C. 2002. Radiation-induced thyroid carcinogenesis as a function of time and dietary iodine supply: An in vivo model of tumorigenesis in the rat. Endocrinology 143:2584-2592.
4. Busnardo B, De Vido D. 2000. The epidemiology and etiology of differentiated thyroid carcinoma. Biomed & Pharmacother 54:322-326.
5. Carter AB, Knudtson KL, Monick MM, Hunninghake GW. 1999. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 274:30858-30863.
6. Chen K, Maines MD. 2000. Nitric oxide induces heme oxygenase-1 via mitogen-activated protein kinases ERK and p38. Cell Mol Biol 46:609-617.
7. Chen K, Gunter K, Maines MD. 2000. Neurons over-expressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 75:304-313.
8. Chen GG, Lee JF, Wang SH, Chan UP, Ip PC, Lau WY. 2002. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer. Life Sci 70:2631-2646.
9. Davis JN, Kucuk O, Djuric Z, Sarkar FH. 2001. Soy isoflavone supplementation in healthy men prevents NF-kappaB activation by TNF-alpha in blood lymphocytes. Free Rad Biol Med 30:1293-1302.
10. Delaney JK, Mauzerall D, Drummond GS, Kappas A. 1988. Photophysical properties of Sn-porphyrins: Potential clinical implications. Pediatrics 81:498-504.
11. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
12. Elbirt KK, Whitmarsh AJ, Davis RJ, Bonkovsky HL. 1998. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J Biol Chem 273:8922-8931.
13. Elledge RM, Clark GM, Fuqua SA, Yu YY, Allred DC. 1994. p53 protein accumulation detected by five different antibodies: Relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res 54:3752-3757.
14. Galanti MR, Hansson L, Bergstrom R, Wolk A, Hjartaker A, Lund E, Grimelius L, Ekbom A. 1997. Diet and the risk of papillary and follicular thyroid carcinoma: A population-based case-control study in Sweden and Norway. Cancer Causes Control 8:205-214.
15. Gilmore TD. 1999. The Rel/NF-kappaB signal transduction pathway: Introduction. Oncogene 18:6842-6844.
16. Glattre E, Haldorsen T, Berg JP, Stensvold I, Solvoll K. 1993. Norwegian case-control study testing the hypothesis that seafood increases the risk of thyroid cancer. Cancer Causes Control 4:11-16.
17. Goodman AI, Choudhury M, da Silva JL, Schwartzman ML, Abraham NG. 1997. Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med 214:54-61.
18. Harach HR, Escalante DA, Day ES. 2002. Thyroid cancer and thyroiditis in Salta, Argentina: A 40-yr study in relation to iodine prophylaxis. Endocr Pathol 13:175-181.
19. Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, Nath KA. 2001. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 60:2181-2191.
20. Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W. 2002. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 55:396-405.
21. Maines MD, Abrahamsson PA. 1996. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology 47:727-733.
22. McCoubrey WK Jr, Huang TJ, Maines MD. 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247:725-732.
23. Mitsiades CS, Poulaki V, Mitsiades N. 2003. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer. J Endocrinol 178:205-216.
24. Murphy BJ, Laderoute KR, Vreman HJ, Grant TD, Gill NS, Stevenson DK, Sutherland RM. 1993. Enhancement of heme oxygenase expression and activity in A431 squamous carcinoma multicellular tumor spheroids. Cancer Res 53:2700-2703.
25. Nyska A, Lomnitski L, Maronpot R, Moomaw C, Brodsky B, Sintov A, Wormser U. 2001. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. Arch Toxicol 74:768-774.
26. Petrache I, Otterbein LE, Alam J, Wiegand GW, Choi AM. 2000. Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol 278:L312-L319.
27. Takahashi S, Mikami T, Watanabe Y, Okazaki M, Okazaki Y, Okazaki A, Sato T, Asaishi K, Hirata K, Narimatsu E, et al. 1994. Correlation of heat shock protein 70 expression with estrogen receptor levels in invasive human breast cancer. Am J Clin Pathol 101:519-525.
28. Tuyt LM, Dokter WH, Birkenkamp K, Koopmans SB, Lummen C, Kruijer W, Vellenga E. 1999. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. J Immunol 162:4893-4902.
29. Waldman T, Kinzler KW, Vogelstein B. 1995. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55:5187-5190.
30. Wang SH, Phelps E, Utsugi S, Baker JR Jr. 2001. Susceptibility of thyroid cancer cells to 7-hydroxystaurosporine-induced apoptosis correlates with Bcl-2 protein level. Thyroid 11:725-731.
31. Williams JL, Nath N, Chen J, Hundley TR, Gao J, Kopelovich L, Kashfi K, Rigas B. 2003. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: Implications for chemoprevention. Cancer Res 63:7613-7618.
32. Zechner D, Craig R, Hanford DS, McDonough PM, Sabbadini RA, Glembotski CC. 1998. MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem 273:8232-8239.